BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37956614)

  • 21. New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis.
    Sadrkhanloo M; Paskeh MDA; Hashemi M; Raesi R; Bahonar A; Nakhaee Z; Entezari M; Beig Goharrizi MAS; Salimimoghadam S; Ren J; Nabavi N; Rashidi M; Dehkhoda F; Taheriazam A; Tan SC; Hushmandi K
    Pathol Res Pract; 2023 Nov; 251():154902. PubMed ID: 37922723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osthole Induces Cell Cycle Arrest and Inhibits Migration and Invasion via PTEN/Akt Pathways in Osteosarcoma.
    Wang L; Yang L; Lu Y; Chen Y; Liu T; Peng Y; Zhou Y; Cao Y; Bi Z; Liu T; Liu Z; Shan H
    Cell Physiol Biochem; 2016; 38(6):2173-82. PubMed ID: 27185245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eldecalcitol induces apoptosis and autophagy in human osteosarcoma MG-63 cells by accumulating ROS to suppress the PI3K/Akt/mTOR signaling pathway.
    Zhang C; Huang C; Yang P; Li C; Li M
    Cell Signal; 2021 Feb; 78():109841. PubMed ID: 33217539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.
    Liu GL; Yang HJ; Liu B; Liu T
    J Cell Biochem; 2017 Oct; 118(10):3424-3434. PubMed ID: 28322459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway.
    Wei Z; Xia K; Zheng D; Gong C; Guo W
    Mol Med; 2023 Oct; 29(1):133. PubMed ID: 37789274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HTRA3 transcriptionally inhibited by FOXP1 suppresses tumorigenesis of osteosarcoma via the PTEN/PI3K/AKT pathway.
    Tong Z; Shen Y; Yuan Q; Yu H
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119553. PubMed ID: 37527738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
    Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
    Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.
    Tan S; Chao R
    Discov Med; 2023 Jun; 35(176):300-311. PubMed ID: 37272097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIP13 knockdown inhibits the proliferation, migration, invasion, and promotes apoptosis by suppressing PI3K/AKT signaling pathway in U2OS cells.
    Yu DC; Chen XY; Zhou HY; Yu DQ; Yu XL; Hu YC; Zhang RH; Zhang XB; Zhang K; Lin MQ; Gao XD; Guo TW
    Mol Biol Rep; 2022 Apr; 49(4):3055-3064. PubMed ID: 35032258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blue LED causes autophagic cell death in human osteosarcoma by increasing ROS generation and dephosphorylating EGFR.
    He M; Yan G; Wang Y; Gong R; Lei H; Yu S; He X; Li G; Du W; Ma T; Gao M; Yu M; Liu S; Xu Z; Idiiatullina E; Zagidullin N; Pavlov V; Cai B; Yuan Y; Yang L
    J Cell Mol Med; 2021 Jun; 25(11):4962-4973. PubMed ID: 33960631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
    Zheng J; Liu C; Shi J; Wen K; Wang X
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway.
    Liu M; Zhang J; Dong H; Wang W
    J Cell Physiol; 2019 Nov; 234(11):20879-20887. PubMed ID: 31001861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effects of Interleukin-33 (IL-33) on Osteosarcoma Cell Viability, Apoptosis, and Epithelial-Mesenchymal Transition are Mediated Through the PI3K/AKT Pathway.
    Wang S; Zhao G; Zhao S; Qiao Y; Yang H
    Med Sci Monit; 2020 Apr; 26():e920766. PubMed ID: 32312946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway.
    Li B; Yang Y; Jiang S; Ni B; Chen K; Jiang L
    Int J Oncol; 2012 Nov; 41(5):1809-19. PubMed ID: 22948234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ROS play an important role in ATPR inducing differentiation and inhibiting proliferation of leukemia cells by regulating the PTEN/PI3K/AKT signaling pathway.
    Feng Y; Hua X; Niu R; Du Y; Shi C; Zhou R; Chen FH
    Biol Res; 2019 May; 52(1):26. PubMed ID: 31053167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piperlongumine induces apoptosis and G
    Zhou J; Huang Z; Ni X; Lv C
    Toxicol In Vitro; 2020 Jun; 65():104775. PubMed ID: 31987842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
    J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway.
    Li ZZ; Wang YL; Yu YH; Xing YL; Ji XF
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):105-112. PubMed ID: 30657552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP.
    Wang Y; Huang H; Li Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1458-1465. PubMed ID: 31007083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.